Tag: ResMed
In brief: Resmed evolves brand, Walgreens sells to PE, pharmacy hosts FTC chair
March 12, 2025HME News Staff
SAN DIEGO – Resmed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.
As part of the rebrand, Resmed plans to consolidate its brands, products and services under a single Resmed brand over the next couple of years, creating a more streamlined view for both consumers and health care providers.
“We are at a pivotal moment in health – sleep and breathing health are gaining the attention once reserved for diet and...
In brief: Owens & Minor explores P&HS sale, Grassley challenges UHC, CCS details burnout
February 28, 2025HME News Staff
RICHMOND, Va.– Owens & Minor is looking to sell off its Products & Healthcare Services business, while it remains “bullish” on its Patient Direct business.
The company made the announcement today, as part of its fourth quarter and full-year 2024 earnings results.
“Our commitment to directing capital toward the higher growth and higher margin Patient Direct segment has been increasingly evident in recent years and is consistent with our strategy,” said...
ResMed on sleep health: ‘Millions struggle in silence’
February 27, 2025HME News Staff
SAN DIEGO – People lose an average of nearly three nights of restorative sleep each week, according to a new survey from ResMed.
Despite a trend toward growing awareness of sleep’s importance, many continue to suffer in silence and remain trapped in a cycle of exhaustion, the survey found, with poor sleep impacting everything from work to relationships to mental health.
“Chronic poor sleep impacts our relationships, workplace productivity, and increases the...
ResMed moves to address ‘educational gap’ on PAP devices, GLP-1s
January 31, 2025Liz Beaulieu, Editor
SAN DIEGO – In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep apnea, ResMed is ramping up its education to high-volume prescribers of GLP-1 drugs to reiterate that PAP therapy remains the gold standard.
The FDA announced in late December that it had approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe OSA in adults with obesity. It’s approved for use in combination...
ResMed: ‘(We’re) well-positioned to capitalize on once-in-a-generation opportunities’
January 30, 2025HME News Staff
SAN DIEGO – ResMed reported second quarter 2025 revenue increased to $1.3 billion, a 10% increase on a constant currency basis year over year.
The company reported revenue in the U.S., Canada, and Latin America, excluding Residential Care Software, grew by 12%.
Other financial results for the quarter:
Gross margin improved 300 bps to 58.6%; non-GAAP gross margin improved 230 bps to 59.2%
Income from operations increased 52%; non-GAAP income...
Providers face ‘new era’ in online shopping
December 13, 2024Theresa Flaherty, Managing Editor
YARMOUTH, Maine – ResMed’s decision to add the AirSense 11 to its e-shop is another sign of a shifting market – one that providers have mixed feelings about.
ResMed was already selling its AirSense 10 and AirMini, as well as numerous masks and accessories, on the e-shop for cash purchase, and added the AirSense 11 in October. Inogen, a manufacturer of portable oxygen concentrators, has offered a direct-to-consumer option for years.
“We're seeing that...
ResMed adds AirSense 11 to e-shop
November 22, 2024Liz Beaulieu, Editor
SAN DIEGO – ResMed has added the AirSense 11 to its e-shop for cash purchase in a move that has upset providers who say they are still on allocation for this CPAP device.
When contacted by HME News, a company spokesperson confirmed that the AirSense 11 joined the AirSense 10 and AirMini, as well as numerous masks and accessories, on the company’s e-shop on Oct. 28.
“The expansion of our online shop reflects our broader commitment to developing a holistic channel...
ResMed targets resupply, rePAP for growth
October 25, 2024Liz Beaulieu, Editor
SAN DIEGO – ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, performance and patient eligibility in real-time, available to all HME providers, not just those using Brightree.
The company reported a “really solid” 10% increase in sales for mask and accessories in the United States, Canada and Latin America for the first quarter of fiscal year 2025, on an “extraordinary comp” of 23% for...
ResMed highlights ‘ongoing momentum’
October 25, 2024HME News Staff
SAN DIEGO – ResMed’s revenue increased by 11% to $1.2 billion for the first quarter of 2025.
It reported net income of $311.4 million, a 42% increase.
Other results:
Gross margin improved 420 bps to 58.6%; non-GAAP gross margin improved 320 bps to 59.2%
Income from operations increased 34%; non-GAAP income from operations up 27%
Operating cash flow of $326 million
Diluted earnings per share of $2.11; non-GAAP diluted earnings per share...
In brief: Geriatric Medical buys DDP, ResMed talks strategy, NCPA launches new PBM ad
October 2, 2024HME News Staff
WOBURN, Mass. – GMSS, the parent company of Geriatric Medical & Surgical Supply, has acquired DDP Medical Supply, significantly expanding its footprint and forming what it says is “the nation’s leading medical supply distribution networks focused on chronic, post-acute and home care providers.”
Both companies will maintain their unique brands and market-focused solutions, while benefiting from increased scale, enhanced distribution infrastructure and expanded service...